{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:42:49Z","timestamp":1787881369799,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejphar.2024.177214","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:50:01Z","timestamp":1734508201000},"page":"177214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Protective effect of Astragaloside II against lung injury in COPD based on mTORC1\/GSK-3\u03b2 signaling pathway"],"prefix":"10.1016","volume":"988","author":[{"given":"Fengxi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6911-6322","authenticated-orcid":false,"given":"Xuejian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2483-8838","authenticated-orcid":false,"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177214_bib1","series-title":"Disclosure: Brandon Brown Declares No Relevant Financial Relationships with Ineligible Companies","article-title":"Chronic Obstructive Pulmonary Disease, StatPearls, Treasure Island (FL) ineligible companies. Disclosure: avais Raja declares no relevant financial relationships with ineligible companies","author":"Agarwal","year":"2023"},{"key":"10.1016\/j.ejphar.2024.177214_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1476-9255-7-34","article-title":"Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD","volume":"7","author":"Arunachalam","year":"2010","journal-title":"J. Inflamm."},{"key":"10.1016\/j.ejphar.2024.177214_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00018-009-0163-7","article-title":"Key factors in mTOR regulation","volume":"67","author":"Bai","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2024.177214_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1081\/COPD-120028701","article-title":"Alveolar macrophages as orchestrators of COPD","volume":"1","author":"Barnes","year":"2004","journal-title":"COPD"},{"key":"10.1016\/j.ejphar.2024.177214_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2024.177214_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev-physiol-022516-034314","article-title":"Senescence in COPD and its comorbidities","volume":"79","author":"Barnes","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2024.177214_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.03.00040703","article-title":"Chronic obstructive pulmonary disease: molecular and cellular mechanisms","volume":"22","author":"Barnes","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2024.177214_bib8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/path.5364","article-title":"Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine","volume":"250","author":"Brandsma","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2024.177214_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/720689","article-title":"Regulatory role of GSK-3 beta on NF- kappa B, nitric oxide, and TNF- alpha in group A streptococcal infection","volume":"2013","author":"Chang","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2024.177214_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2174\/092986709787549280","article-title":"Bronchial asthma, chronic obstructive pulmonary disease and NF-kappaB","volume":"16","author":"Charokopos","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177214_bib11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/07853890.2019.1639809","article-title":"The elevated CXCL5 levels in circulation are associated with lung function decline in COPD patients and cigarette smoking-induced mouse model of COPD","volume":"51","author":"Chen","year":"2019","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejphar.2024.177214_bib12","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.biopha.2018.11.002","article-title":"Memantine ameliorates pulmonary inflammation in a mice model of COPD induced by cigarette smoke combined with LPS","volume":"109","author":"Cheng","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.177214_bib13","doi-asserted-by":"crossref","first-page":"L612","DOI":"10.1152\/ajplung.00390.2007","article-title":"Mechanisms of cigarette smoke-induced COPD: insights from animal models","volume":"294","author":"Churg","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2024.177214_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1139\/Y08-053","article-title":"Inhibitory effects of astragaloside IV on ovalbumin-induced chronic experimental asthma","volume":"86","author":"Du","year":"2008","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177214_bib15","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/01.CCM.0000178350.21839.44","article-title":"GSK-3beta inhibitors attenuate the organ injury\/dysfunction caused by endotoxemia in the rat","volume":"33","author":"Dugo","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2024.177214_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.shk.0000238059.23837.68","article-title":"Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation","volume":"27","author":"Dugo","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2024.177214_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93203","article-title":"mTOR pathway activation drives lung cell senescence and emphysema","volume":"3","author":"Houssaini","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2024.177214_bib18","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41598-020-63071-y","article-title":"Author Correction: increased circulating beta2-adrenergic receptor autoantibodies are associated with smoking-related emphysema","volume":"10","author":"Hu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177214_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/383022a0","article-title":"Transcription. A growing coactivator network","volume":"383","author":"Janknecht","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.177214_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fphar.2019.00094","article-title":"Astragalin suppresses inflammatory responses and bone destruction in mice with collagen-induced arthritis and in human fibroblast-like synoviocytes","volume":"10","author":"Jia","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177214_bib21","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4963","article-title":"Astragaloside regulates lncRNA LOC100912373 and the miR-17-5p\/PDK1 axis to inhibit the proliferation of fibroblast-like synoviocytes in rats with rheumatoid arthritis","volume":"48","author":"Jiang","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2024.177214_bib22","first-page":"1344","article-title":"Effect of astragalosides on long non-coding RNA expression profiles in rats with adjuvant-induced arthritis","volume":"44","author":"Jiang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2024.177214_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/370223a0","article-title":"Nuclear protein CBP is a coactivator for the transcription factor CREB","volume":"370","author":"Kwok","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.177214_bib24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.177214_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2024.177214_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1164\/rccm.201503-0593OC","article-title":"Restoration of corticosteroid sensitivity in chronic obstructive pulmonary disease by inhibition of mammalian target of rapamycin","volume":"193","author":"Mitani","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2024.177214_bib27","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1248\/bpb.32.1559","article-title":"Pulmonary emphysema induced by cigarette smoke solution and lipopolysaccharide in Guinea pigs","volume":"32","author":"Mizutani","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2024.177214_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000362843","article-title":"Protective effects of astragaloside IV against ovalbumin-induced lung inflammation are regulated\/mediated by T-bet\/GATA-3","volume":"94","author":"Qiu","year":"2014","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2024.177214_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/15548627.2017.1389823","article-title":"Autophagy and inflammation in chronic respiratory disease","volume":"14","author":"Racanelli","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2024.177214_bib30","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1164\/rccm.201512-2368OC","article-title":"Therapeutic targeting of the IL-6 trans-signaling\/mechanistic target of rapamycin complex 1 Axis in pulmonary emphysema","volume":"194","author":"Ruwanpura","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2024.177214_bib31","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2024.177214_bib32","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/biom5031266","article-title":"NF-kappaB signaling in chronic inflammatory airway disease","volume":"5","author":"Schuliga","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2024.177214_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41698-021-00148-5","article-title":"The Aurora kinase\/beta-catenin axis contributes to dexamethasone resistance in leukemia","volume":"5","author":"Shah","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.ejphar.2024.177214_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019","volume":"53","author":"Singh","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2024.177214_bib35","article-title":"Astragaloside II ameliorated podocyte injury and mitochondrial dysfunction in streptozotocin-induced diabetic rats","volume":"12","author":"Su","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177214_bib36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4161\/auto.5.5.8504","article-title":"Rapamycin inhibits mTORC1, but not completely","volume":"5","author":"Thoreen","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2024.177214_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2024.177214_bib38","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.4049\/jimmunol.1701681","article-title":"MTOR suppresses cigarette smoke-induced epithelial cell death and airway inflammation in chronic obstructive pulmonary disease","volume":"200","author":"Wang","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2024.177214_bib39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/CM9.0000000000000107","article-title":"Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats","volume":"132","author":"Weng","year":"2019","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejphar.2024.177214_bib40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/15548627.2019.1628536","article-title":"Inactivation of MTOR promotes autophagy-mediated epithelial injury in particulate matter-induced airway inflammation","volume":"16","author":"Wu","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2024.177214_bib41","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1016\/j.biortech.2010.04.100","article-title":"Enhanced extraction of astragalosides from Radix Astragali by negative pressure cavitation-accelerated enzyme pretreatment","volume":"101","author":"Yan","year":"2010","journal-title":"Bioresour. Technol."},{"key":"10.1016\/j.ejphar.2024.177214_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.biopha.2016.03.025","article-title":"AstragalosideII inhibits autophagic flux and enhance chemosensitivity of cisplatin in human cancer cells","volume":"81","author":"Yang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.177214_bib43","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.immuni.2016.08.017","article-title":"mTORC1 and mTORC2 kinase signaling and glucose metabolism drive follicular helper T cell differentiation","volume":"45","author":"Zeng","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2024.177214_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2006.09.019","article-title":"S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt","volume":"24","author":"Zhang","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2024.177214_bib45","article-title":"Astragalus saponins and its main constituents ameliorate ductular reaction and liver fibrosis in a mouse model of DDC-induced cholestatic liver disease","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177214_bib46","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1097-2765(00)80066-0","article-title":"Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP\/p300","volume":"1","author":"Zhong","year":"1998","journal-title":"Mol. Cell"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992400904X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992400904X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T10:15:17Z","timestamp":1742033717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992400904X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":46,"alternative-id":["S001429992400904X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177214","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of Astragaloside II against lung injury in COPD based on mTORC1\/GSK-3\u03b2 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177214"}}